Parallax Volatility Advisers’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,000
Closed -$5.05M 2164
2024
Q3
$5.05M Hold
10,000
0.01% 789
2024
Q2
$4.87M Hold
10,000
0.01% 728
2024
Q1
$5.4M Buy
+10,000
New +$5.46M 0.01% 713
2022
Q3
Sell
-1,900
Closed -$665K 3220
2022
Q2
$665K Sell
1,900
-2,300
-55% -$938K ﹤0.01% 1795
2022
Q1
$2.3M Sell
4,200
-1,300
-24% -$684K ﹤0.01% 1308
2021
Q4
$3.63M Sell
5,500
-7,800
-59% -$4.9M ﹤0.01% 886
2021
Q3
$8.27M Buy
+13,300
New +$8.94M 0.01% 703
2021
Q1
Sell
-26,200
Closed -$13.1M 1576
2020
Q4
$13.1M Sell
26,200
-8,500
-24% -$3.8M 0.01% 645
2020
Q3
$13.6M Buy
34,700
+12,800
+58% +$4.73M 0.01% 861
2020
Q2
$7.23M Buy
21,900
+7,500
+52% +$2.17M 0.01% 927
2020
Q1
$3.49M Buy
14,400
+9,900
+220% +$2.58M ﹤0.01% 1011
2019
Q4
$1.17M Buy
+4,500
New +$1.19M ﹤0.01% 1461

Other funds holding IDXX

Parallax Volatility Advisers's IDXX Position: Q4 2024 in Review

Parallax Volatility Advisers sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 6,472 shares — an estimated $3.27M sold.

Parallax Volatility Advisers first reported a position in IDXX in Q2 2015 and held it in 17 quarters. The position peaked at $3.27M in Q3 2024. 1,124 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Parallax Volatility Advisers reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 6,472 Idexx Laboratories shares in Q4 2024, an estimated $3.27M.
  • Parallax Volatility Advisers first reported a position in Idexx Laboratories in Q2 2015 and held it in 17 quarters.
  • Parallax Volatility Advisers's Idexx Laboratories position peaked at $3.27M in Q3 2024.
  • 1,124 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Parallax Volatility Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.